Viewing Study NCT00042068


Ignite Creation Date: 2025-12-24 @ 5:32 PM
Ignite Modification Date: 2025-12-24 @ 5:32 PM
Study NCT ID: NCT00042068
Status: COMPLETED
Last Update Posted: 2013-11-01
First Post: 2002-07-22
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis
Sponsor: Boehringer Ingelheim
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module